pharmaceutical investing NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN”
U.S. FDA Approves Cost Recovery for PLX-PAD under Expanded Access Program in the Treatment of Critical Limb Ischemia
CoTec Investment Mkango and Hypromag Announces First Production from Commercial-Scale Recycled Rare Earth Alloy Production in the UK
IsoEnergy and Purepoint Confirm Uranium Discovery in Initial Drilling at the Dorado Joint Venture Project
SAGA Metals Confirms Significant Oxide Layering in the Northwest of the 100% owned Radar Titanium Project in Labrador, Canada
Kobo Resources Launches Limited Edition Jersey to Support Village Communities Through Kobo Cup CSR Initiative
